Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vania Tiestsche de Moraes Hungria"'
Autor:
Douglas Vivona, Carolina Tosin Bueno, Vania Tiestsche de Moraes Hungria, Maria de Lourdes Lopes Ferrari Chauffaille, Rosario D. C. Hirata, Carlos S. Chiattone, Luciene Terezina Lima, Maria Aparecida Zanichelli, Elvira Maria Guerra-Shinohara, Mario Hiroyuki Hirata
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Genetic variations in membrane transporters may contribute to imatinib mesylate (IM) resistance in chronic myeloid leukemia (CML). Objective To investigate the relationship between SLCO1B3, SLCO1A2, and ABCA3 polymorphisms and IM response in CML pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede8d4190669f975f639eb39685dccf8
https://doi.org/10.1179/1607845414y.0000000181
https://doi.org/10.1179/1607845414y.0000000181
Autor:
Luciene Terezina Lima, Douglas Vivona, Carolina Tosin Bueno, Alice Cristina Rodrigues, Luiza Saldanha Ribeiro Barros, Maria de Lourdes Lopes Ferrari Chauffaille, Vania Tiestsche de Moraes Hungria, Carlos S. Chiattone, Greyce Kelly Steinhorst Alcantara, Elvira Maria Guerra-Shinohara
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Oncology Letters
Universidade de São Paulo (USP)
instacron:USP
Oncology Letters
Despite the high efficacy of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) patients, some individuals develop resistance due to impaired bioavailability. It has been previously demonstrated that the haplotypes for ATP‑binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f521c9dda84f527d943579bdf2b842d6
Autor:
I. Zalcberg, Vania Tiestsche de Moraes Hungria, P. Tanaka, Luciene Da Cruz Oliveira, Adriana Quero, Jc Barros, C.S.P. Lima, Gislaine Oliveira-Duarte, A Maiolino, AL Miguel Peres, RP Magalhães, Eduardo Magalhães Rego, M. Nucci, Ecm Miranda, E. Braggio, Mercante, Irene Lorand-Metze, Carmino Antonio De Souza
Publikováno v:
Blood. 112:3703-3703
Introduction: Autologous stem cell transplantation (ASCT) remains the mainstay of treatment of multiple myeloma (MM) in patients Methods: From October 2003 to July 2008, 212 untreated patients induction with 3–5 cycles of VAD; high-dose cyclophosph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb37b56e04585f839b37e1b62e24612b
https://doi.org/10.1182/blood.v112.11.3703.3703
https://doi.org/10.1182/blood.v112.11.3703.3703